
Konar MF VSD Occluder
Lifetech Scientific developed the Konar-MF VSD Occluder as a next-generation transcatheter device for ventricular septal defect (VSD) closure procedures. The system is designed to support complex anatomical applications while emphasizing low-profile delivery architecture and optimized design strategies intended to reduce atrioventricular (AV) block risk during intervention.
Advanced VSD Closure Device with Low AV Block Risk and Low-Profile Delivery System
Lifetech Scientific developed the Konar-MF VSD Occluder as a next-generation transcatheter device for ventricular septal defect (VSD) closure procedures. The system is designed to support complex anatomical applications while emphasizing low-profile delivery architecture and optimized design strategies intended to reduce atrioventricular (AV) block risk during intervention.
One of the most important advantages of the Konar-MF VSD Occluder is its design philosophy focused on supporting low AV block rates. In perimembranous VSD procedures, the proximity of the cardiac conduction system creates an important procedural concern regarding atrioventricular conduction disturbances. The Konar-MF platform utilizes softer disc structures, optimized radial force distribution, and flexible nitinol mesh architecture to minimize pressure on surrounding conduction tissue.
Clinical experience and published reports have associated the Konar-MF system with low rates of permanent AV block, contributing to its growing adoption particularly in pediatric cardiology applications. This design strategy is especially valuable in younger patient populations where preservation of the conduction system is critically important.
Another major advantage of the device is its low-profile delivery system architecture. The Konar-MF is compatible with smaller delivery sheaths, helping improve vascular access safety while minimizing procedural trauma, particularly in pediatric patients with small vascular anatomy.
The low-profile system additionally supports improved catheter maneuverability during both antegrade and retrograde procedural approaches. This enhanced navigation capability provides important advantages for operators managing complex VSD anatomies.
The Konar-MF VSD Occluder features a unique asymmetrical dual-disc design capable of adapting to multiple VSD morphologies. The device can be used in muscular and selected perimembranous VSD cases, offering broad anatomical versatility. Its short and flexible waist segment is designed to improve conformity with septal tissue and support stable implantation.
The nitinol mesh structure provides excellent flexibility and shape-memory characteristics, while integrated polyester fabric promotes rapid thrombosis formation and effective defect closure. Electropolished implant surfaces further contribute to enhanced biocompatibility.
The Konar-MF system also supports controlled retrieval and repositioning during implantation. Operators can reposition or fully retrieve the device if necessary, improving procedural safety and precision in complex interventions.
Through minimally invasive transcatheter treatment, the Konar-MF VSD Occluder offers significant advantages compared with open surgical repair procedures, including reduced procedural trauma, shorter hospitalization, and faster recovery. As a result, percutaneous VSD closure continues to gain wider adoption in modern pediatric and structural heart intervention practices.
Compared with competing VSD occluder systems, the Konar-MF stands out through its low AV block-oriented design strategy, low-profile delivery architecture, and strong anatomical adaptability. It is increasingly recognized as a valuable next-generation platform for complex VSD anatomies and pediatric interventions.
In summary, the Konar-MF VSD Occluder is an advanced transcatheter closure system developed for modern VSD treatment applications. Through its low AV block-focused design, low-profile delivery system, and flexible implant architecture, the device provides safe and controlled interventional therapy for structural heart procedures.
Let’s define the right product and collaboration structure together.
Reach out to our team for more information about product groups, production approach, and collaboration processes.